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Abstract
Penicillin-binding proteins (PBPs) catalyze the final stages of bacterial cell wall biosynthesis. PBPs form
stable covalent complexes with -lactam antibiotics, leading to PBP inactivation and ultimately cell death.
To understand more clearly how PBPs recognize -lactam antibiotics, it is important to know their energies
of interaction. Because -lactam antibiotics bind covalently to PBPs, these energies are difficult to measure
through binding equilibria. However, the noncovalent interaction energies between -lactam antibiotics and
a PBP can be determined through reversible denaturation of enzyme–antibiotic complexes. Escherichia coli
PBP 5, a D-alanine carboxypeptidase, was reversibly denatured by temperature in an apparently two-state
manner with a temperature of melting (Tm) of 48.5°C and a van’t Hoff enthalpy of unfolding (HVH) of 193
kcal/mole. The binding of the -lactam antibiotics cefoxitin, cloxacillin, moxalactam, and imipenem all
stabilized the enzyme significantly, with Tm values as high as +4.6°C (a noncovalent interaction energy
of +2.7 kcal/mole). Interestingly, the noncovalent interaction energies of these ligands did not correlate with
their second-order acylation rate constants (k2/K). These rate constants indicate the potency of a covalent
inhibitor, but they appear to have little to do with interactions within covalent complexes, which is the state
of the enzyme often used for structure-based inhibitor design.
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Penicillin-binding proteins (PBPs) are involved in the bio-
synthesis of bacterial cell wall peptidoglycan. All bacteria
analyzed to date have multiple PBPs, which function to
crosslink the cell wall peptides (transpeptidation) and to
remove the C terminal D-alanine residue from cell wall pep-
tides (carboxypeptidation). PBPs are the targets of -lactam
antibiotics, which react with these enzymes to form stable
covalent complexes, leading to inactivation of the PBP and
ultimately to cell death (Tipper and Strominger 1965; Wise
and Park 1965; Ghuysen and Dive 1994). A broad range of
-lactam antibiotics, including penicillins, cephalosporins,
monobactams, and carbapenems, are used clinically, and
seemingly subtle structural differences have dramatic ef-
fects on their biological activity (Neuhaus and Georgopap-
adakou 1992).
Despite much interest in understanding the molecular in-
teractions of -lactams with PBPs, their interaction energies
have been difficult to determine. The noncovalent first en-
counter complex between the antibiotic and enzyme pro-
ceeds quickly to an acyl-enzyme adduct by attack of the
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catalytic serine hydroxyl on the carbonyl carbon of the
-lactam ring (Fig. 1). Because of this covalent bond for-
mation and the resultant -lactam ring opening, -lactam
antibiotics essentially bind irreversibly to PBPs, and there is
no equilibrium between the free and covalently bound li-
gand. Hence, a thermodynamic interaction energy (Ginteraction)
cannot be determined for the covalent complex.
Previously, differential protein stability has been used to
measure the thermodynamic complementarity of both -lac-
tam and non--lactam ligands for -lactamase enzymes
(Rahil and Pratt 1994; Beadle et al. 1999), which are struc-
turally and functionally related to PBPs (Kelly et al. 1986;
Massova and Mobashery 1998; Fonze et al. 1999; Davies et
al. 2001). Rather than measuring the equilibrium constant
between bound and free ligand, this technique measures the
equilibrium constant between folded and unfolded protein
(Schellman 1976), in the presence and absence of a ligand.
The free enzyme and the enzyme in complex with a cova-
lent ligand are reversibly denatured by temperature; each
denaturation is described by a temperature of melting (Tm),
a van’t Hoff enthalpy of denaturation (HVH), and an en-
tropy of denaturation (Su). Because thermal denaturation
does not break covalent bonds, the difference between the
unfolding energy of the free enzyme and that of the covalent
complex reflects the noncovalent interaction energy be-
tween the ligand and the enzyme in the covalent complex
(Ginteraction). Using a thermodynamic cycle (Fig. 2), this
process can be described by the following equation: Gin-
teraction + Gcovalent + Gu1 − G3 − Gcovalent − Gu2 
0. If we assume that the noncovalent interactions between
the ligand and the denatured state are negligible (i.e., G3
 0) and that the covalent energies between the enzyme
and the ligand (Gcovalent) are the same in the folded and
unfolded states, then: Ginteraction  Gu2 − Gu1 
Gu. Thus, the noncovalent interaction energy is equal to
the net differential stability between the apo- and ligand-
bound enzyme. This method closely resembles that used to
determine stabilization energies of mutant enzymes, and it is
reliable provided that the denaturation of both the apo- and
bound enzyme is reversible, can be modeled as two-state,
and the noncovalent energy of the denatured state is not
significantly affected by the covalently bound ligand.
In this study, we investigated the complementarity of
-lactam antibiotics for E. coli PBP 5, a D-alanine carboxy-
peptidase, by reversible thermal denaturation of free PBP 5
and PBP 5 covalently bound to several -lactam antibiotics.
These studies provide the first quantitative measurement of
the noncovalent interaction energies of a PBP with cova-
lently bound -lactam antibiotics. Intriguingly, these non-
covalent interaction energies do not correlate with the sec-
ond-order rate constants for formation of the acyl–enzyme
complex (k2/K), which are considered the best indicators of
the inhibitory potency of -lactam antibiotics with PBPs
(Frere et al. 1975; Frere et al. 1992; Jamin et al. 1993;
Graves-Woodward and Pratt 1998; Lu et al. 1999).
Results
Denaturation of PBP 5
PBP 5 was reversibly denatured by temperature (Fig. 3).
When monitored by far-UV CD, a measure of secondary
structure, PBP 5, has an average Tm of 47.9°C and a HVH
of 156 kcal/mole. Following denaturation, the sample was
immediately cooled, and 100% of the folded CD signal
returned. Moreover, cooling the denatured sample at a rate
of 2°C/min, the same rate at which it had been denatured
produced a renaturation curve that overlaid almost exactly
the denaturation curve (data not shown). These data suggest
that renaturation follows the same pathway as denaturation
and that the folded and unfolded states are in thermody-
namic equilibrium throughout the transition, a requirement
for thermodynamic analysis.
To investigate whether PBP 5 exhibited two-state behav-
ior, thermal denaturations and renaturations of PBP 5 were
also monitored by fluorescence emission following excita-
tion at 285 nm, a measure of tertiary structure. By fluores-
cence, PBP 5 has an average Tm of 48.5°C and a HVH of
193 kcal/mole (Fig. 3). The Tm and HVH values of PBP 5
when monitored by fluorescence were essentially the same
as those when monitored by far-UV CD. These data suggest
that the values are independent of spectral technique, con-
sistent with PBP 5 melting in a two-state fashion.
Fig. 1. A simplified mechanism for the binding of -lactam antibiotics to PBPs.
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Denaturation of PBP–-lactam adducts
To assess the complementarity of -lactams for PBP 5,
covalent complexes were formed by incubation of PBP 5
with each of cefoxitin, cloxacillin, imipenem, or moxalac-
tam. These complexes were then reversibly denatured by
temperature, and the Tm and HVH values were determined.
Binding of each of these antibiotics increased the stability of
PBP 5 (Fig. 4; Table 1); cloxacillin and imipenem stabilized
PBP 5 to a greater extent than either cefoxitin or moxalac-
tam. We note that the van’t Hoff enthalpies of denaturation
are often reduced in the ligand complexes. We suspect that
this reflects the difficulty in fitting to the fluorescent dena-
turation curves, which are innately temperature dependent.
However, a direct comparison of the free energies was also
made by comparing the equilibria of unfolding at a refer-
ence temperature using the Gibbs-Helmholtz equation. By
picking a temperature within the range of melting tempera-
tures, namely 51.3°C, extrapolation errors are minimized.
For these analyses, we used the van’t Hoff enthalpies of
each curve to determine equilibria. The two methods gave
similar values for Gu (Table 1). The free energies of
stabilization reported are valid near the temperature of melt-
ing, but some caution is warranted when extrapolating these
values to room temperature.
Determination of second-order rate constants for
formation of the acyl–enzyme complex
The second-order rate constant (k2/K) is considered the
best indicator of inhibitory activity of a -lactam antibiotic
against a PBP (Frere et al. 1992). The k2/K constant of
[125I]penicillin V ([125I]IPV) for PBP 5 was determined
from a time course of the formation of the acyl–enzyme
complex as described in Materials and methods. The k2/K
values of cefoxitin, cloxacillin, imipenem, and moxalactam
with PBP 5 were then determined by competition of
[125I]IPV binding. No clear relationship between the Gu
and k2/K values was evident (Table 1).
Discussion
-Lactam binding to PBP 5
The -lactam antibiotics cloxacillin, cefoxitin, moxalactam,
and imipenem all stabilized the enzyme when covalently
complexed with PBP 5. Surprisingly, their noncovalent in-
teraction energies do not correlate with the second-order
rate constants (k2/K) for these compounds. Based on k2/K
values, the order of potency of the -lactams for inhibiting
PBP 5 is: cefoxitin > imipenem > moxalactam > cloxacillin.
Based on Gu values, the order of complementarity of the
-lactams for PBP 5 is: cloxacillin  imipenem > cefoxitin
> moxalactam. Strikingly, cloxacillin, the -lactam that best
complements PBP 5 in the acyl state, is the least potent
inhibitor of PBP 5. Thus, -lactam antibiotics with greater
complementarity to PBP 5 in the acyl–enzyme complex, as
shown by more favorable interaction energies, are not better
inhibitors of PBP 5.
The discrepancy between the interaction energies and
second-order rate constants becomes less troubling when
Fig. 2. A thermodynamic cycle for determining the
noncovalent interaction energy (Ginteraction) be-
tween PBP 5 and a -lactam. This process can be
described by the following equation: Ginteraction +
Gcovalent + Gu1 − G3 − Gcovalent − Gu2  0.
If we assume that the noncovalent interactions be-
tween the ligand and the denatured state are negli-
gible (i.e., G3  0), and that the covalent energies
between the enzyme and the ligand (Gcovalent) are
the same in the folded and unfolded states, then:
Ginteraction  Gu2 − Gu1  Gu.
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one considers that these values are determined for different
states of the enzyme and ligand. The second-order acylation
rate constant (k2/K) measures the fit of the ligand to the
active site in the precovalent complex multiplied by the rate
of the chemical step. The noncovalent interaction energies
measure the complementarity of a -lactam to a PBP in the
acylated, postcovalent complex. Because acylated, ring-
opened -lactam antibiotics bound to PBPs differ signifi-
cantly from their precovalent, closed-ring forms (Kelly et al.
1989), and because there is no kinetic component to the
noncovalent interaction energies measured by stability, the
lack of correlation between the acylation rate constants and
noncovalent interaction energies can be understood. An ef-
fective -lactam must complement the active site of its tar-
get sufficiently to allow rapid acylation, be chemically pre-
disposed to the acylation reaction itself, and then deacylate
very slowly. The rate of deacylation can depend on many
factors, including steric blockage of hydrolytic attack (Pat-
era et al. 2000). Once acylated, complementarity within the
acyl–enzyme complex may play only a secondary role in
determining how effective an inhibitor is. In this light, ef-
forts to improve inhibitors by improving complementarity
within covalent complexes may be misguided.
Conclusions
The ability to determine the energetic complementarity of
-lactams for PBP 5 provides a method for understanding
their interactions in the covalent complex, which is the state
often used as a basis for structure-based drug design. The
only requirements for such thermodynamic analyses are the
reversible denaturation of the enzyme and enzyme–ligand
complex and the ability to isolate a stable enzyme–ligand
complex. This method may be used to study the binding of
a broad variety of covalent ligands and their enzyme targets.
However, it is clear that improving the noncovalent comple-
mentarity within a covalently bound complex will not nec-
essarily improve the potency of an inhibitor.
Materials and methods
Enzyme preparation
A soluble form of PBP 5 constructed by deletion of the last 17
amino acids from the C terminus was expressed in the cytoplasm
of E. coli. PBP 5 was precipitated from the soluble fraction of cell
lysates with 50% ammonium sulfate, and the protein was redis-
solved in 50 mM Tris, 150 mM NaCl, pH 7.5 (Buffer A), and
purified by covalent ampicillin affinity chromatography as previ-
ously described (Nicholas and Strominger 1988). The enzyme was
dialyzed against Buffer A, concentrated to 6–8 mg/mL, and stored
at −80°C.
Fig. 3. Reversible, thermal denaturation of PBP 5 as monitored by two
independent spectral techniques: (A) Far-UV CD. PBP 5 has an average
Tm of 47.9°C and a HVH of 156 kcal/mole. (B) Fluorescence. PBP 5 has
an average Tm of 48.5°C and a HVH of 193 kcal/mole.
Fig. 4. Reversible, two-state thermal denaturation of PBP 5 alone and with
various -lactam antibiotics. Black squares, PBP 5 alone; red circles, PBP
5–moxalactam complex; blue diamonds, PBP 5–cefoxitin complex; green
triangles, PBP 5–cloxacillin complex; orange circles, PBP 5–imipenem
complex.
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Sample preparation
PBP 5 was diluted to a concentration of approximately 6 g/mL in
3.5 mL of 50 mM potassium phosphate, 200 mM potassium chlo-
ride, 38% (v/v) ethylene glycol, pH 6.8. The buffer was prepared
using ACS reagent grade potassium chloride from Sigma Chemi-
cal, potassium phosphate from Aldrich Chemical, spectroscopic
grade ethylene glycol from Sigma, and doubly deionized water.
To form antibiotic–PBP 5 complexes, PBP 5 was incubated with
a 50- to 100-fold molar excess of cloxacillin, moxalactam, cefoxi-
tin (all from Sigma Chemical), or imipenem for periods of 5 min
to 45 min. We note that some -lactam antibiotics took a longer
incubation time to reach a constant, maximal Tm; we report the
largest reproducible Tm observed. An aliquot of the incubation
mixture was then added to 3.5 mL of buffer solution, and the
denaturation experiments were performed (see below). Gu val-
ues were determined by the method of Schellman for all com-
plexes of enzyme with inhibitor (Becktel and Schellman 1987):
Gu = Tm  Sapo-enzyme ( 1)
where
Sapo-enzyme = HVHTm ( 2)
Because of the variations observed in the HVH values of the
thermal denaturations, we also compared the Gu values within
the transition region directly using the Gibbs-Helmholtz equation:
G = H° − TS° + CpT − T° − TlnTT° ( 3)
For each denaturation, the G value was calculated using its ther-
modynamic parameters (Tm, HVH, S) as the reference values
(T°, H°, S°) with T set to a temperature within the range of the
observed Tm values, specifically at 51.3°C. Gu values were
calculated as the difference between the G value of each complex
and the enzyme alone. Positive Gu values indicate increases in
the Tm, hence stabilization; negative Gu values indicate de-
creases in the Tm, hence destabilization.
Thermal denaturation as monitored by CD
and fluorescence
CD and fluorescence experiments were performed in a Jasco J-715
spectropolarimeter with a fluorescence emission attachment,
which allows both spectra to be measured simultaneously. Tem-
perature was controlled with a Jasco PTC-348WI peltier-effect
temperature controller, using an in-cell probe to measure tempera-
ture. All solutions were stirred with a magnetic stirbar. Quartz cells
with a 1-cm path length from Hellma (Jamaica, NY) were used for
all experiments. The program EXAM (Kirchhoff 1993) was used
to calculate all Tm and HVH values. For these analyses, the
change in heat capacity upon denaturation, (Cp) was set to 6.0
kcal/mol·K, consistent with theoretical considerations (Myers et al.
1995); neither the Tm nor the HVH values varied appreciably with
Cp values.













+Cloxacillin +4.6 (±0.2) 88.4 (±6.5) +2.7 (±0.2) +2.2 (±0.2) 104 (±30)
+Imipenem +4.4 (±0.2) 97.8 (±7.2) +2.6 (±0.4) +2.2 (±0.4) 790 (±170)
+Cefoxitin +3.4 (±0.2) 118 (±11) +2.0 (±0.4) +2.0 (±0.4) 2750 (±590)
+Moxalactam +1.6 (±0.1) 122 (±6.5) +1.0 (±0.1) +1.3 (±0.1) 420 (±60)
a Determined by the method of Schellman (Becktel and Schellman 1987): Gu  Tm · Sapo-enzyme.
b Determined by direct comparison of the equilibria within the unfolding region, namely at T  51.3°C, using the Gibbs-Helmholtz equation.
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Samples were monitored for helical content by CD in the far-
UV region at 223 nm, and for the tertiary structure by fluorescence
emission following excitation at 285 nm. Thermal melting was
performed at ramp rates of 2°C/min. Reversibility was judged
using two criteria: the return of the original CD signal upon quick
cooling and retracing of the path of the denaturation curve on slow
cooling (at a ramp rate equal to that of unfolding, 2°C/min).
Acylation rate constant determination
Second-order rate constants for acylation (k2/K) of PBP 5 by
-lactam antibiotics were determined from a time course of for-
mation of the acyl–enzyme complex essentially as described (Frere
et al. 1992), except k2/K for [
125I]IPV was determined by a time
course for acyl–enzyme formation at a single concentration of
[125I]IPV at 30°C (van der Linden et al. 1994). Briefly, PBP 5 (4.0
g; 100 pmole) was diluted into 80 L of 40 M [125I]IPV in 50
mM Tris·HCl, 500 mM NaCl, 10% glycerol. At 15-sec intervals up
to 1 min (and 2-min intervals after that), 10-L aliquots were
removed and added to 5 L 3× SDS-PAGE sample buffer. The
samples were submitted to electrophoresis on a 10% polyacryl-
amide gel, and the levels of [125I]IPV–PBP 5 complex were quan-
titated with ImageQuant software following phosphoimager analy-
sis on a Storm 840 Phosphoimager (Molecular Dynamics, Sun-
nyvale, CA). The k2/K; value was calculated by dividing the
apparent first-order rate constant derived from the time course by
the concentration of [125I]IPV.
The second-order rate constants (k2/K) for cefoxitin, imipenem,
cloxacillin, and moxalactam were determined by the competition
method. Variable concentrations of the unlabeled antibiotic were
mixed with a fixed concentration of [125I]IPV (40 M), followed
by addition of PBP 5 (0.25 g; 6.3 pmole), and the mixture was
incubated at 30°C for 10 min. The level of radioactivity bound to
the proteins was quantitated as described above. k2/K constants





where ECo and ECL represent the ([
125I]IPV–PBP 5) formed in the
absence and presence of the unlabeled antibiotic, respectively, and
CU and CL represent the concentrations of the unlabeled and la-
beled antibiotic, respectively (Frere et al. 1992).
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